Neuronetics (STIM) News Today $1.03 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Neuronetics to Unveil Q3 2024 Financial ResultsOctober 31 at 9:05 AM | msn.comNeuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference CallOctober 29, 2024 | globenewswire.comNeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with DepressionOctober 14, 2024 | globenewswire.comNeuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder MeetingsOctober 4, 2024 | prnewswire.comBrainsWay: More Cash, More UncertaintyOctober 1, 2024 | seekingalpha.comNeuronetics Expands TMS Access for Adolescents with DepressionSeptember 27, 2024 | msn.comHealth Care Service Corporation Adds First-Line TMS Coverage for AdolescentsSeptember 25, 2024 | globenewswire.comNeuronetics Expands TMS Coverage, Enhancing Access for MDD TreatmentSeptember 21, 2024 | msn.comNeuronetics Enhances NeuroStar Therapy with New FeaturesSeptember 19, 2024 | msn.comExpanded Health Policies Enhance TMS Therapy Access for Adolescents and AdultsSeptember 19, 2024 | globenewswire.comNeuroStar® Releases Software Upgrades to Elevate Patient CareSeptember 16, 2024 | globenewswire.comRobert Cascella Purchases 100,000 Shares of Neuronetics, Inc. (NASDAQ:STIM) StockSeptember 14, 2024 | insidertrades.comInsider Buying: Neuronetics, Inc. (NASDAQ:STIM) Director Buys 25,000 Shares of StockSeptember 7, 2024 | insidertrades.comNeuronetics’ Breakthrough: How NeuroStar Therapy Is Transforming Lives Amid Rising Suicide RatesSeptember 5, 2024 | msn.comNeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful StoriesSeptember 3, 2024 | globenewswire.comNeuronetics, Inc. (NASDAQ:STIM) Director Glenn P. Muir Purchases 12,776 SharesAugust 31, 2024 | insidertrades.comNeuronetics Celebrates Two Years of NeuroStar UniversityAugust 21, 2024 | msn.comNeuronetics, Inc. (NASDAQ:STIM) Director Robert Cascella Buys 35,000 SharesAugust 20, 2024 | insidertrades.comRobert Cascella Buys 35,000 Shares of Neuronetics, Inc. (NASDAQ:STIM) StockAugust 17, 2024 | insidertrades.comWilliam Blair Downgrades Neuronetics (STIM)August 14, 2024 | msn.comNeuronetics, Inc. (NASDAQ:STIM) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | msn.comNeuronetics Acquires Greenbrook TMS, Enhancing Mental Health Care DeliveryAugust 14, 2024 | msn.comNeuronetics, Inc. (STIM) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | seekingalpha.comNeuronetics, Inc. Q2 Loss Increases, Misses EstimatesAugust 12, 2024 | markets.businessinsider.comNeuronetics agrees to merge with Canadian company; stock price plummetsAugust 12, 2024 | bizjournals.comSTIM Stock Earnings: Neuronetics Misses EPS, Misses Revenue for Q2 2024August 12, 2024 | msn.comNeuronetics and Greenbrook TMS Announce Definitive Agreement to MergeAugust 12, 2024 | globenewswire.comNeuronetics Reports Record Second Quarter 2024 Financial and Operating ResultsAugust 12, 2024 | globenewswire.comNeuronetics earnings: here's what Wall Street expectsAugust 12, 2024 | markets.businessinsider.comNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)August 5, 2024 | globenewswire.comNeuronetics (STIM) Scheduled to Post Earnings on MondayNeuronetics (NASDAQ:STIM) will be releasing earnings before the market opens on Monday, August 12, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=614214)August 5, 2024 | marketbeat.comNeuronetics to Present at Canaccord Genuity Growth ConferenceAugust 2, 2024 | msn.comNeuroStar Partners With This Is My Brave to Recognize Teen Mental Health MonthAugust 1, 2024 | globenewswire.comNeuronetics to Announce Q2 Financial Results and Host Conference CallJuly 31, 2024 | msn.comNeuronetics to Present at the Canaccord Genuity 44th Annual Growth ConferenceJuly 31, 2024 | finance.yahoo.comChester County medical technology company enters into $90M debt dealJuly 30, 2024 | bizjournals.comNeuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive AdvisorsJuly 30, 2024 | globenewswire.comNeuronetics (NASDAQ:STIM) shareholders have endured a 85% loss from investing in the stock three years agoJuly 29, 2024 | finance.yahoo.comNeuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference CallJuly 29, 2024 | globenewswire.comNeuronetics, Inc. (NASDAQ:STIM) CEO Sells $45,907.80 in StockJuly 23, 2024 | insidertrades.comBrainsWay: An Interesting Niche ConcernJuly 22, 2024 | seekingalpha.comAetna Policy Update Expands TMS Availability for Adolescents With DepressionJuly 22, 2024 | globenewswire.comInsider Selling: Neuronetics, Inc. (NASDAQ:STIM) CEO Sells 12,075 Shares of StockJuly 19, 2024 | insidertrades.comShort Interest in Neuronetics, Inc. (NASDAQ:STIM) Increases By 31.6%Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) was the target of a significant growth in short interest during the month of June. As of June 30th, there was short interest totalling 119,100 shares, a growth of 31.6% from the June 15th total of 90,500 shares. Based on an average trading volume of 143,600 shares, the short-interest ratio is currently 0.8 days.July 13, 2024 | marketbeat.comCalifornia Medicaid Adds TMS Access for 14.8 Million Adolescents and AdultsJuly 11, 2024 | globenewswire.comBlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed AdolescentsJuly 10, 2024 | globenewswire.comNeuronetics (NASDAQ:STIM) Trading Up 1.7%Neuronetics (NASDAQ:STIM) Trading 1.7% HigherJuly 5, 2024 | marketbeat.comNeuroStar® Launches Better Me Provider Program NationwideJuly 1, 2024 | globenewswire.comNeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual MeetingJune 13, 2024 | globenewswire.comNeuronetics, Inc. (NASDAQ:STIM) Short Interest Up 436.7% in MayNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) saw a significant growth in short interest in May. As of May 31st, there was short interest totalling 96,600 shares, a growth of 436.7% from the May 15th total of 18,000 shares. Based on an average daily volume of 164,400 shares, the days-to-cover ratio is currently 0.6 days.June 12, 2024 | marketbeat.com Get Neuronetics News Delivered to You Automatically Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here STIM Media Mentions By Week STIM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. STIM News Sentiment▼0.000.43▲Average Medical News Sentiment STIM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. STIM Articles This Week▼22▲STIM Articles Average Week Get Neuronetics News Delivered to You Automatically Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PYPD News Today KRMD News Today TLSI News Today SRTS News Today EDAP News Today PDEX News Today FONR News Today MGRM News Today MODD News Today VANI News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:STIM) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuronetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuronetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
